For Patients · Theranostics · Radioligand Therapy

Radioligand Therapy

We treat
what we see.

Theranostics is built on a foundational principle: we see what we treat, and we treat what we see. A diagnostic molecular imaging scan identifies the precise location of specific cellular targets on abnormal tissue. A matched therapeutic agent — delivered in a controlled clinical setting — binds to those same targets and delivers localized radiation directly to them, sparing healthy tissue.

See + treat

Theranostic principle

Targeted

Localized radiation

Multiple

Treatment cycles

Private suite

Administration

How it works

See the target, then treat it.

The same molecular target that shows up on a diagnostic scan becomes the address for therapy — radiation delivered precisely where it is needed.

1
Image

A diagnostic scan locates the specific cellular targets on abnormal tissue.

2
Match

A therapeutic agent is paired to bind those same targets.

3
Treat

Delivered by infusion, it carries localized radiation directly to the targets.

4
Monitor

You are monitored throughout, with care continuing across cycles.

Designed to concentrate radiation on the target while sparing surrounding healthy tissue.

Eligibility

Who is this for?

Radioligand therapies are prescribed for specific clinical conditions — most commonly certain forms of metastatic prostate cancer and neuroendocrine tumors — in patients who meet specific eligibility criteria defined by their medical team.

How to prepare

A personalized plan.

Because these therapies are individualized, preparation begins with a detailed consultation and a step-by-step plan built for your specific protocol.

01
Consultation first

Preparation begins with a detailed consultation with our precision oncology and nuclear medicine team.

02
Hydration

Proper hydration before and after therapy helps your body naturally clear any excess therapeutic agent.

03
Personalized instructions

Your clinical coordinator will provide a complete, step-by-step plan for your specific protocol.

What to expect

Comfortable, private, monitored.

Therapy is administered in a comfortable, private suite by our specialized nuclear medicine team, via intravenous infusion. You will be monitored throughout. Following treatment, brief radiation-safety precautions apply regarding close contact with others for a short period; these will be explained thoroughly by your team. Therapy courses typically consist of multiple cycles spaced several weeks apart.

Step 01

Consultation & personalized plan

Step 02

Infusion in a private suite, fully monitored

Step 03

Brief radiation-safety precautions

for a short period after

Step 04

Repeat cycles

several weeks apart

Your team will map your full course — number of cycles and spacing — to your specific protocol.

Aftercare

After your therapy.

Radioligand therapy delivers targeted radiation, so brief safety precautions apply for a short period after each session. Your team explains exactly what they involve before you leave.

01
Radiation-safety precautions

For a short period, you keep some distance during close, prolonged contact with others — especially pregnant people and young children. Your team gives you specific, written guidance.

02
Hydration

Drinking plenty of water before and after therapy helps your body clear any excess agent naturally.

03
A course of treatment

These therapies are usually given as multiple cycles spaced several weeks apart. Your coordinator maps out the full schedule with you.

Cost

What it costs.

Pricing on request

Radioligand therapy

We publish our prices up front. This service is quoted individually because the cost depends on the protocol your physician orders. Contact us and we will confirm the full cost, and any funding options, before you book.

FAQ

Radioligand therapy, answered.

It pairs diagnosis with treatment: a scan first shows exactly where the cellular targets are, then a matched therapy binds to those same targets and delivers radiation directly to them, sparing healthy tissue as much as possible.

It is prescribed for specific conditions — most commonly certain metastatic prostate cancers and neuroendocrine tumours — in patients who meet eligibility criteria set by their medical team. A diagnostic scan first confirms the target is present.

The therapy is given as an intravenous infusion in a private suite, with monitoring throughout. The infusion itself is not painful.

Treatment is usually a course of several cycles, spaced a few weeks apart. Your care team confirms the plan for your specific protocol.

Brief radiation-safety precautions apply around close contact with others for a short period after each session. Your team explains these thoroughly and provides written instructions.

Yes. Radioligand therapy begins with a consultation and requires referral and eligibility assessment by your medical team.

Keep exploring

Related services.

PSMA PET/CT

The diagnostic scan behind prostate-cancer theranostics.

Learn more

DOTATATE PET/CT

Imaging for neuroendocrine tumors.

Learn more

All patient services

Browse every imaging and therapy service.

Learn more

Why Initio

Everything under one roof.

At Initio the diagnostic scan that confirms your target, the radiopharmacy that produces the agent, and the suite where therapy is delivered are all under one roof, run by one specialised team. See it, then treat it — without hand-offs between facilities.

Targeted therapy begins with a consultation. Our team will guide every step.

Prefer to talk first? Call +1 (604) 678-9274, email info@initiomedical.ca, or send us a message.

Looking for another service? Back to For Patients.